Skip to main content
You have permission to edit this article.
Edit
Nebraska could wind up with $100 million from opioid settlements
editor's pick

Nebraska could wind up with $100 million from opioid settlements

  • Updated
  • 0
{{featured_button_text}}

Animation about how Opioids effect the body. Describing the benefits and risks involved.

Nebraska is in line to potentially receive $100 million as part of national settlements over the distribution of opioid drugs that contributed to a national addiction epidemic.

A settlement announced this week requires three major drug distribution companies -- AmerisourceBergen, Cardinal Health and McKesson -- to pay a combined $21 billion over 18 years to a coalition of states and local governments. The settlement also requires drugmaker Johnson & Johnson to pay $5 billion over nine years.

It's the second opioid-related settlement Nebraska has been a party to. Earlier this year, Attorney General Doug Peterson announced the state would receive $2.59 million as part of a $573 million settlement with McKinsey & Company, one of the world’s largest consulting firms which worked with drug manufacturers in a promotional role.

Nebraska also is a party to a settlement being negotiated with Purdue Pharma.

Peterson said he expects the state to receive approximately $100 million total from the three cases over the next 18 years.

Most of that money will go directly into Nebraska's Opioid Recovery Fund to be used for treatment and prevention purposes. Some of the money will go to local counties and cities that joined the suit individually.

Reach the writer at 402-473-2647 or molberding@journalstar.com.

On Twitter @LincolnBizBuzz.

Locations

Get Government & Politics updates in your inbox!

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News